Rusmir Softic

Prof. Dr. Rusmir Softic

Department of Psychiatry, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina, Federation of, Bosnia and Herzegovina
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015
Verified
Journal Article
Closed access
Rusmir SofticRusmir Softic
Rusmir Softic
ASAlija Sutovic
Alija Sutovic
EAEsmina Avdibegović
Esmina Avdibegović
EOEnes Osmanović
Enes Osmanović
EBElvir Bećirović
Elvir Bećirović
MHMitra Mirković Hajdukov
Mitra Mirković Hajdukov

1 January 2026 in Medical Archives
Verified
Journal Article
Open access
PDF file
Rusmir SofticRusmir Softic
Rusmir Softic
ATAlmerisa Tufekcic
Almerisa Tufekcic
JKJasmina Klebic
Jasmina Klebic
ASAida Sehanovic
Aida Sehanovic
Background: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, and abrupt discontinuation can lead to severe neuropsychiatric destabilization, including withdrawal catatonia. High-potency dopamine D2 receptor antagonists may further precipitate neuroleptic malignant syndrome (NMS), a condition with substantial clinical overlap with malignant catatonia. Objective: This report follows CARE guidelines to provide a structured and transparent description of a complex case involving abrupt clozapine withdrawal and rapid antipsychotic transition. Case presentation: This report describes a male patient with schizophrenia who developed malignant catatonia with overlapping NMS features following abrupt clozapine withdrawal and initiation of fluphenazine. Conclusion: The case underscores the importance of cautious antipsychotic transitions and early recognition of catatonia and NMS.


19 March 2019
Verified
Conference Paper
Closed access
Rusmir SofticRusmir Softic
Rusmir Softic
07 - INSIGHT IN SCH: CORRELATION WITH EXECUTIVE FUNCTIONING |

1 January 2019 in Materia Socio Medica
Verified
Journal Article
Open access
ETEmir Tupkovic
Emir Tupkovic
Rusmir SofticRusmir Softic
Rusmir Softic
JKJasmina Klebic
Jasmina Klebic
SSSenada Selmanovic
Senada Selmanovic
EBElvir Becirovic
Elvir Becirovic
MSMiralem Smajic
Miralem Smajic
Cognitive impairment is common finding in individuals with PTSD. Dysfunctional metacognitions in variety of anxiety disorders can represent generic vulnerability for anxiety disorders, as well as elements that contribute to maintaining the disorder. There is little empirical information about metacognition in war veterans with PTSD, and its relation to cognitive and/or social, occupational and psychological functioning. to determine the values and reciprocal correlations of different aspects of metacognition, with cognitive and global functioning in outpatient war veterans with PTSD. The study was conducted on 25 war veterans (24 male), with confirmed diagnosis of PTSD by a trained psychiatrist, average age 48,5±6,2 (38-63) years, with average duration of symptoms of 9,9±4,7 (0,5-16) years. We used the Metacognitions questionnaire, Mini Mental Status Examination, and Global Assessment of Functioning Scale to assess metacognition, cognitive impairment, and global functioning. Median values of Metacognitions questionnaire subcomponents, Global Assessment of Functioning Scale and Mini Mental Status Examination were determined, and also reciprocal correlations of all parameters expressed with Spearman Rank Correlation. 12 patients (48%) had impaired cognitive function. Significant negative correlation of score on Mini Mental Status Examination, and negative beliefs about worry is observed (r=-0,4278, p=0,034), as well as non significant correlations between rest of metacognition subscales and score on Mini Mental Status Examination. Cognitive self-consciousness showed high positive correlation with Global Assessment of Functioning Scale (r =0,7436, p<0,0001). Follow up of metacognitions, cognitive and global functioning, and its relations, may have an important role in assessment of war veterans with posttraumatic stress disorder.

5 June 2020 in Psymedica
Verified
Journal Article
Open access
PDF file
Rusmir SofticRusmir Softic
Rusmir Softic
SOSadina Osmanović
Sadina Osmanović
MHMitra Mirković Hajdukov
Mitra Mirković Hajdukov
EBElvir Bećirović
Elvir Bećirović
Deluzioni poremećaj spada u kategoriju psihotičnih poremećaja. Nekada smatran rijetkim, u psolejdnje vrijeme pomjeren je u centar kliničke pažnje. Još uvijek nema dokaza o efikasnom tretmanu ovog poreećaja. Somatski tip deluzionog poremećaja je posebno intrigantan jer pacijenti odbijaju prihvatiti da su psihički oboljeli i, po pravilu se protive psihijatrijskom liječenju. Prikaz slučaja: pacijent dobi od 40 godina primljen je na Kliniku za psihijatriju sa tegobama vezanim uz somatske sisteme. Čvrsto je vjerovao da ima intracerebralnu aneurizmu. Predhodno je podvrgavan obimnim medicinskim ispitivanjima i pregledima koji su bili negativni. Započet je tretman sa malim dozama risperidona i paroksetina bez ikakvog pozitivnog učinka tokom tri sedmice liječenja. Pacijent je insisitrao na otpustu navodeći da želi biti podvrgnut detaljnijim dijagnostičkim procedurama. Nakon otpusta prekinuo je sa medikacijom i nije se pojavio na zakazanim kontrolnim pregledima. Zaključak: iako rijedak, somatski tip deluzionog poremećaja je prisutan u kliničkoj praksi, posebno na nepsihijatrijskim odjeljenjima. S obzirom na teškoću prihvaćanja psihičkog porijekla tegoba, očekivan je jednostrani prekid terapijskog odnosa od strane pacijenta.